CIK 0000921114
- Non-accelerated filer
- Smaller reporting company
Armata Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ARMP
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- Operating
- EIN
- 911549568
- Phone
- +1 310-665-2928
- Business address
- 5005 MCCONNELL AVE, LOS ANGELES, CA, 90066
- Former names
- AmpliPhi Biosciences Corp, TARGETED GENETICS CORP /WA/
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale 10% owner sold 14,200 shares at an average $0.71 ($10,043)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale 10% owner sold 25,000 shares at an average $0.73 ($18,263)
- 4 Open-market sale 10% owner sold 25,453 shares at an average $0.76 ($19,325)
- 4 Open-market sale 10% owner sold 37,500 shares at an average $0.76 ($28,675)
- 4 Open-market sale 10% owner sold 26,200 shares at an average $0.77 ($20,211)
- 4 Open-market sale 10% owner sold 33,000 shares at an average $0.78 ($25,791)
- 4 Open-market sale 10% owner sold 36,500 shares at an average $0.81 ($29,481)
- 4/A Open-market sale 10% owner sold 73,500 shares at an average $0.84 ($61,584)
- 4/A Open-market sale 10% owner sold 35,098 shares at an average $0.79 ($27,791)
- 4/A Open-market sale 10% owner sold 17,000 shares at an average $0.81 ($13,726)
- 4/A Open-market sale 10% owner sold 74,632 shares at an average $0.80 ($59,671)
- 4 Open-market sale 10% owner sold 73,500 shares at an average $0.84 ($61,584)
- 4 Open-market sale 10% owner sold 35,098 shares at an average $0.79 ($27,791)
- 4 Open-market sale 10% owner sold 17,000 shares at an average $0.81 ($13,726)
- 4 Derivatives Options or other derivatives
Page 12 of 14 · 267 filings